Periinterventional cardiovascular risk and the methods for its reduction in coronary heart disease patients undergoing percutaneous coronary intervention

QR Code

Periinterventional cardiovascular risk and the methods for its reduction in coronary heart disease patients undergoing percutaneous coronary intervention

Such periinterventional complications of percutaneous coronary intervention (PCI) as myocardial infarction (MI), “no-reflow/slow-flow” phenomenon, and stroke, affect long-term survival. Therefore, their risk should be effectively stratified and reduced. The existing approaches for predicting the ris...

Full description

Saved in:

Bibliographic Details
Main Authors:	K. A. Nazarova, O. V. Khilkevich, G. K. Kiyakbaev, Zh. D. Kobalava, V. S. Moiseev
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 1970-01-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	coronary heart disease percutaneous coronary intervention periinterventional risk myocardial infarction statins beta-adrenoblockers ivabradine
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/2186
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN
by: N. G. Gogolashvili
Published: (2015-09-01)

Could secondary prevention of coronary heart disease be more effective?
by: V. I. Makolkin
Published: (2010-02-01)

Stable coronary heart disease treatment: focus on beta-adrenoblockers
by: V. I. Makolkin
Published: (2008-12-01)

Current position of beta-adrenoblockers in coronary heart disease management: information for clinicians
by: I. A. Libov, et al.
Published: (2009-04-01)

HIGH DOSES OF STATINS BEFORE PERCUTANEOUS CORONARY INTERVENTION: WHETHER THERE ARE REASONS TO USE?
by: I. S. Yavelov, et al.
Published: (2017-09-01)

Beta-adrenoblockers in coronary heart disease patients. Evidencebased medicine data
by: A. E. Radzevich, et al.
Published: (1970-01-01)

IMMEDIATE RESULTS OF DELAYED PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: S. D. Chevgun, et al.
Published: (2017-12-01)

Heart rate-reducing agents ivabradine and beta-adrenoblockers in the management of patients with stable effort angina
by: Z. M. Galeeva, et al.
Published: (2011-02-01)

Prognostic Value of Cardiac Troponin T and Sex in Patients Undergoing Elective Percutaneous Coronary Intervention
by: Yukinori Harada, et al.
Published: (2016-12-01)

ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS
by: V. A. Sulimov
Published: (2016-01-01)

BIVALIRUDIN AND PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ACUTE CORONARY SYNDROME: THEORY AND PRACTICE
by: O. V. Averkov
Published: (2012-06-01)

RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: V. A. Sulimov, et al.
Published: (2015-12-01)

ROLE OF MEDICATIONS WITH NEGATIVE CHRONOTROPIC EFFECT IN THE TREATMENT OF PATIENTS WITH CORONARY HEART DISEASE AND HEART FAILURE
by: M. G. Glezer, et al.
Published: (2013-10-01)

Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With 3‐Vessel Coronary Artery Disease and Diabetes
by: Ryaan EL‐Andari, et al.
Published: (2025-06-01)

CLINICAL OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION WITH DRUG ELUTING STENT IN STABLE ANGINA PATIENTS
by: D. I. Tomilova, et al.
Published: (2017-10-01)

Combination antihypertensive therapy in patients with arterial hypertension and coronary heart disease
by: T. E. Morozova, et al.
Published: (2013-08-01)

The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention
by: A. S. Tereshchenko, et al.
Published: (2019-05-01)

Antianginal treatment of stable angina: focus on heart rate reduction
by: Yu. M. Lopatin
Published: (1970-01-01)

Comorbidities and Percutaneous Coronary Intervention in Elderly Patients with Acute Coronary Syndrome
by: M. Yu. Gilyarov, et al.
Published: (2021-05-01)

Choice of dual antiplatelet therapy in patients with acute coronary syndrome after percutaneous coronary intervention
by: A. N. Golosova, et al.
Published: (2020-08-01)

Immediate and short-term outcomes of percutaneous coronary intervention in patients with stable and multivessel coronary artery disease, intolerant to coronary artery bypass grafting
by: Sh. Sh. Zaynobidinov, et al.
Published: (2025-05-01)

Impact of Frailty on the First 30 Days of Major Cardiac Events in Elderly Patients with Coronary Artery Disease Undergoing Elective Percutaneous Coronary Intervention
by: Rachmat Hamonangan, et al.
Published: (2016-09-01)

Impact of Frailty on the First 30 Days of Major Cardiac Events in Elderly Patients with Coronary Artery Disease Undergoing Elective Percutaneous Coronary Intervention
by: Rachmat Hamonangan, et al.
Published: (2016-09-01)

Acute Coronary Syndrome after Percutaneous Coronary Intervention: State of the Problem and Clinical Practice Data
by: I. S. Egorova, et al.
Published: (2023-01-01)

ROLE OF GENETIC FACTORS IN THE DEVELOPMENT OF CLOPIDOGREL RESISTANCE AMONG PATIENTS REFERRED FOR PERCUTANEOUS CORONARY INTERVENTIONS
by: S. T. Matskeplishvili, et al.
Published: (2013-08-01)

THE INFLUENCE OF DIABETES MELLITUS ON THE COURSE AND OUTCOMES OF MYOCARDIAL INFARCTION IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTIONS
by: B. U. Mardanov, et al.
Published: (2016-12-01)

Influence of multimorbidity on the risk of events in men with chronic coronary artery disease after myocardial infarction and percutaneous coronary intervention
by: D. V. Dedov, et al.
Published: (2023-12-01)

predictors of long-term fatal cardiovascular events after planned percutaneous coronary interventions
by: E. O. Vershinina, et al.
Published: (2018-12-01)

Distal radial access as an alternative to conventional radial access in coronary angiography and percutaneous coronary interventions
by: A. V. Korotkikh, et al.
Published: (2025-01-01)

Application of a Nomogram Model in Predicting Postoperative Delirium Following Percutaneous Coronary Intervention
by: Yaxin Xiong, et al.
Published: (2025-06-01)

Outcomes of percutaneous coronary intervention in COVID-19-positive acute coronary syndrome patients: a retrospective study in Vietnam
by: Duy Cao Phuong Le, et al.
Published: (2025-07-01)

Comparison of clinical course and therapeutic strategy in patients with isolated myocyte bridges of coronary arteries or combined coronary artery pathology
by: Z. A. Bagmanova, et al.
Published: (2011-10-01)

Antiplatelet medications in acute coronary syndromes and percutaneous coronary interventions: focus on tirofiban
by: T. A. Batyraliev, et al.
Published: (2008-12-01)

Efficiency and safety of various dual antiplatelet therapy strategies in patients undergoing percutaneous coronary intervention due to myocardial infarction
by: S. B. Aksentiev, et al.
Published: (2021-08-01)

Myocardial revascularization by percutaneous coronary intervention in senile patients with chronic total occlusion: a modern view of the problem
by: E. R. Atamanyuk, et al.
Published: (2022-02-01)

CLINICAL CASE HISTORY OF EPTIFIBATIDE USE DURING CORONARY INTERVENTION IN PATIENT WITH CORONARY FAILURE
by: K. A. Kireev, et al.
Published: (2015-09-01)

Effectiveness, safety, and endothelial function effects of atorvastatin lipid-lowering therapy in coronary heart disease patients undergoing percutaneous coronary intervention
by: M. P. Mal’gina, et al.
Published: (2007-06-01)

STATINS IN ACUTE CORONARY SYNDROMES
by: A. L. Alyavi, et al.
Published: (2019-03-01)

TRANSRADIAL APPROACH DURING PERCUTANEOUS CORONARY INTERVENTIONS. PART 1. EVIDENCE BASE FOR APPLYING A TRANSRADIAL APPROACH
by: Sh. T. Zhamgyrchiev, et al.
Published: (2016-06-01)

Middle-term results of percutaneous coronary intervention with standard metallic stent “Ephesos II” implantation in patients with coronary heart disease
by: T. A. Batyraliev, et al.
Published: (2011-08-01)